Form 4: Palantir Director's Spouse Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Lauren Elaina Friedman Stat, a Palantir Technologies Inc. director, reports that her spouse sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

  • On February 4, 2025, Lauren Elaina Friedman Stat's spouse sold 11,794 shares of Palantir Technologies Inc. Class A Common Stock at a price of $102.8 per share.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on September 11, 2024.
  • Following the transaction, Ms. Stat directly owns 62,139 shares of Class A Common Stock and indirectly owns 88,129 shares through her spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.

Industry Context

This filing is a routine disclosure of insider trading activity. Rule 10b5-1 trading plans are common mechanisms for corporate insiders to sell shares while avoiding accusations of trading on non-public information.

Stakeholder Impact

  • The stock sale by a director's spouse could have a minor impact on shareholder sentiment, but is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

DateDescription
2024-04-26Date of Issuer's Proxy Statement filed with the SEC.
2024-09-11Date the Rule 10b5-1 trading plan was entered into.
2025-02-04Date of the stock sale transaction.
2025-02-06Date of the Form 4 filing.

Keywords

Palantir Technologies Inc., PLTR, Form 4, insider trading, Rule 10b5-1, Lauren Elaina Friedman Stat, stock sale, Class A Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.